A new study published in European Urology indicates that genomic study can predict rapid metastatic disease in node-negative, high-risk men managed by radical prostatectomy without adjuvant therapy.
Although rapid metastasis in men treated with radical prostatectomy is relatively uncommon, using tumor genomics to identify these men who have a highly lethal form of metastatic disease is an important advance.
http://genomedx.com/press-releases/study-published-european-urology-shows-decipher-prostate-cancer-classifier-predictive-rapid-metastasis-high-risk-men-prostate-surgery/
This is my story about how I'm currently dealing with my metastatic prostate cancer, which has recently spread to some lymph nodes in my groin. I was on Active Surveillance for about 10 years before it spread, and now I'm turning to the medical community for a go forward solution.
Affiliate disclosure
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.